{
  "id": 859,
  "text": "AIDS, 20, 2337-2344.https://doi.org/10.1097/01.aids.0000253361.63578.14 [35] Paavonen, J., Naud, P., Salmerón, J., et al.(2009) Efficacy of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine against Cervical Infection and Precancer Caused by Oncogenic HPV Types (Patricia): Final Analysis of a Double-Blind, Randomized Study in Young Women.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: AIDS, 20, 2337-2344.https://doi.org/10.1097/01.aids.0000253361.63578.14 [35] Paavonen, J., Naud, P., Salmerón, J., et al.(2009) Efficacy of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine against Cervical Infection and Precancer Caused by Oncogenic HPV Types (Patricia): Final Analysis of a Double-Blind, Randomized Study in Young Women.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "HPV-16/18 AS04佐剂疫苗是专门针对预防宫颈感染和由癌变HPV类型引起的癌前病变而设计的。在年轻女性中进行的双盲、随机研究表明，这种疫苗在预防由HPV-16和HPV-18类型引起的宫颈癌和癌前病变方面具有显著的有效性。这项研究的最终分析表明，接种该疫苗可有效减少这两种主要的致癌HPV类型引起的相关疾病的发生率，从而降低宫颈癌的风险。通过促进免疫系统对HPV-16和HPV-18的反应，该疫苗显著提升了宫颈健康的保护效果。",
  "query": "什么是HPV-16/18 AS04佐剂疫苗在预防年轻女性的宫颈癌和癌前病变方面的有效性？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 什么是HPV-16/18 AS04佐剂疫苗在预防年轻女性的宫颈癌和癌前病变方面的有效性？\n\n<reference text>: AIDS, 20, 2337-2344.https://doi.org/10.1097/01.aids.0000253361.63578.14 [35] Paavonen, J., Naud, P., Salmerón, J., et al.(2009) Efficacy of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine against Cervical Infection and Precancer Caused by Oncogenic HPV Types (Patricia): Final Analysis of a Double-Blind, Randomized Study in Young Women.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "HPV-16/18 AS04佐剂疫苗是专门针对预防宫颈感染和由癌变HPV类型引起的癌前病变而设计的。在年轻女性中进行的双盲、随机研究表明，这种疫苗在预防由HPV-16和HPV-18类型引起的宫颈癌和癌前病变方面具有显著的有效性。这项研究的最终分析表明，接种该疫苗可有效减少这两种主要的致癌HPV类型引起的相关疾病的发生率，从而降低宫颈癌的风险。通过促进免疫系统对HPV-16和HPV-18的反应，该疫苗显著提升了宫颈健康的保护效果。"
}